Relation & Deerfield Announce Powerful New Therapeutics Collab
Relation and Deerfield Management have formed a research collaboration that allows Relation to nominate AI- and biology-derived targets for...
Jon Napitupulu
Nicox’s Surging Growth: Debt Repaid, Cash Secured to 2027
Nicox has repaid all secured debt with Kreos Capital and secured up to €4 million in new unsecured bond...
Coherus Publishes Strong Pharmacology of New CCR8 Antibody
Coherus Oncology has introduced the non-proprietary name tagmokitug for its anti-CCR8 monoclonal antibody and published preclinical and translational clinical...
Soleno Publishes Pivotal Vykat™ XR Study Results
Soleno Therapeutics has published the pivotal randomized withdrawal data for VYKAT XR (diazoxide choline extended-release) in the Journal of...
Syndax Announces Presentation at J.P. Morgan Conference
Syndax Pharmaceuticals will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, following a year...
Halozyme, Skye Bio in New Collaboration for Obesity Drug
Halozyme Therapeutics and Skye Bioscience have signed a non-exclusive global collaboration and license agreement enabling Skye to use Halozyme’s...
Medicus Pharma Names Bonner President and Chief Financial Officer
Medicus Pharma has consolidated financial and operational leadership by appointing President Carolyn Bonner as Chief Financial Officer, following the...
INVO Fertility Aligns Leadership for Growth Strategy
INVO Fertility has realigned its leadership to accelerate a clinic-focused growth strategy. Terah Krigsvold, previously the company’s controller, has...
Nicox Repays Debt, Secures Financial Runway Beyond 2027
Nicox has repaid all secured debt owed to Kreos Capital and secured up to €4 million in new unsecured...
Mesoblast Announces Important New Board of Directors Leadership
Mesoblast has reshaped its board as it transitions from development to commercialization, appointing Philip Facchina as non-executive chair and...